Janardhan S

References (2)

Title : Dipeptidyl peptidase IV inhibitors: a new paradigm in type 2 diabetes treatment - Janardhan_2014_Curr.Drug.Targets_15_600
Author(s) : Janardhan S , Sastry GN
Ref : Curr Drug Targets , 15 :600 , 2014
Abstract :
PubMedSearch : Janardhan_2014_Curr.Drug.Targets_15_600
PubMedID: 24611684

Title : Novel hydrazine derivatives as selective DPP-IV inhibitors: findings from virtual screening and validation through molecular dynamics simulations - Tanwar_2014_J.Mol.Model_20_2118
Author(s) : Tanwar O , Deora GS , Tanwar L , Kumar G , Janardhan S , Alam MM , Shaquiquzzaman M , Akhter M
Ref : J Mol Model , 20 :2118 , 2014
Abstract :
PubMedSearch : Tanwar_2014_J.Mol.Model_20_2118
PubMedID: 24687332